AbbVie gets US antitrust case over Humira trimmed
MLex Summary: AbbVie was granted a motion to dismiss US claims for damages in a case accusing it of entering into illegal agreements with pharmacy benefit managers to ensure that Humira...To view the full article, register now.
Already a subscriber? Click here to view full article